Reliance Capital: ADAG’s Dust, Hinduja’s Drea...

Why does a cancer injection bought by a hospital for ₹11,000 end up costing a patient ₹1.3 lakh? India’s drug pricing system is under scrutiny as the government caps trade margins on hundreds of cancer medicines at 30%. While prices of several drugs have fallen sharply, nearly on ...  Show more

When AI agents book your flights, buy your groceries and pick your hotels, no one is scrolling, and no one sees an ad. So how does the internet make money? Lightspeed India partners Harsha Kumar and Hemanth Mohapatra explain which purchases agents will take over and which will st ...  Show more

In today’s episode for 15th July 2023, we dive into Reliance’s latest attempt to demerge its financial services division and maybe disrupt the industry.

Before we begin today's episode, here's a quick side note —

Building a successful startup ...

Reliance and Disney, former rivals in the streaming market, are teaming up to potentially create India's biggest media conglomerate. The joint venture is reportedly valued at $8.5 billion. But what are the implications of this merger for both companies, and how does it influence ...  Show more

The Adani Group, one of India’s biggest conglomerates, has come under fire from a tiny American research firm. A successful secondary share sale amid a rout in the markets leaves <a href="https://www.economist.com/leaders/2023/01/31/nagging-questions-over-the-adani-empire-wont ...